Compare PEN & RNR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PEN | RNR |
|---|---|---|
| Founded | 2004 | 1993 |
| Country | United States | Bermuda |
| Employees | N/A | 1040 |
| Industry | Medical/Dental Instruments | Property-Casualty Insurers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.9B | 12.8B |
| IPO Year | 2015 | N/A |
| Metric | PEN | RNR |
|---|---|---|
| Price | $328.20 | $311.44 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 17 | 15 |
| Target Price | ★ $357.33 | $323.31 |
| AVG Volume (30 Days) | ★ 488.0K | 219.8K |
| Earning Date | 04-30-2026 | 04-28-2026 |
| Dividend Yield | N/A | ★ 0.51% |
| EPS Growth | ★ 1155.56 | N/A |
| EPS | ★ 4.52 | N/A |
| Revenue | ★ $1,403,665,000.00 | N/A |
| Revenue This Year | $14.34 | N/A |
| Revenue Next Year | $13.71 | $2.96 |
| P/E Ratio | $72.87 | ★ $5.42 |
| Revenue Growth | ★ 17.50 | N/A |
| 52 Week Low | $221.26 | $222.75 |
| 52 Week High | $362.41 | $318.20 |
| Indicator | PEN | RNR |
|---|---|---|
| Relative Strength Index (RSI) | 36.98 | 59.40 |
| Support Level | $326.58 | $288.11 |
| Resistance Level | $338.99 | $312.68 |
| Average True Range (ATR) | 2.06 | 7.26 |
| MACD | 0.12 | 0.91 |
| Stochastic Oscillator | 0.57 | 74.11 |
Penumbra Inc is a thrombectomy company focused on developing technologies for challenging medical conditions such as ischemic stroke, venous thromboembolism (including pulmonary embolism), and acute limb ischemia. Its portfolio includes Computer-Assisted Vacuum Thrombectomy (CAVT), which is designed to remove blood clots throughout the body. The company offers products such as the Artemis Neuro Evacuation Device (used for surgical removal of fluid and tissue from the ventricles and cerebrum), Indigo System, Penumbra System Reperfusion Catheter, LANTERN Delivery Microcatheter, Penumbra Smart Coil, and ACE Reperfusion Catheters, among others. The company generates maximum revenue from the sale of its products in the United States, followed by international markets.
RenaissanceRe Holdings Ltd provides reinsurance and insurance solutions and related services. The company's core products include property, casualty and specialty reinsurance. Revenue is derived from three sources: net premiums earned from the insurance and insurance products sold; net investment income from the investment of capital funds and cash; and other income from the company's joint ventures, advisory services, and other items. The reportable segments of the company are the Property segment which includes catastrophe and other property reinsurance, and the Casualty and Specialty segment which is comprised of casualty and specialty reinsurance. It derives a majority of its revenue from the Casualty and specialty segment.